Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5193 studies found for:    "Lung Neoplasms"
Show Display Options
Rank Status Study
21 Completed Study of Arsenic Trioxide in Small Cell Lung Cancer
Conditions: Lung Cancer;   Cancer of Lung;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Small Cell
Intervention: Drug: Arsenic Trioxide
22 Recruiting Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency
Condition: Lung Neoplasms Accompanied by Respiratory Function Insufficiency
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
23 Completed Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm;   Carcinoma Non-small Cell Lung Cancer Stage IIIA;   Carcinoma Non-small Cell Lung Cancer Stage IIIB;   Carcinoma Non-small Cell Lung Cancer Stage IV
Interventions: Biological: Lucanix™;   Other: Placebo Comparator
24 Completed
Has Results
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
Conditions: Lung Neoplasms;   Carcinoma;   Cancer of the Lung;   Non-Small-Cell Lung Carcinoma
Interventions: Drug: Cetuximab;   Drug: Cisplatin;   Drug: Vinorelbine
25 Recruiting Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer
Conditions: Advanced Non-small Cell Lung Cancer;   Metastatic Non-small Cell Lung Cancer;   Lung Neoplasms
Interventions: Biological: Vigil™;   Drug: Nivolumab
26 Recruiting Trial of CRLX101, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Conditions: Solid Tumors;   Small Cell Lung Carcinoma;   Carcinoma, Non-Small-Cell Lung;   Lung Neoplasms
Interventions: Drug: CRLX101;   Drug: olaparib
27 Recruiting CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
Conditions: Malignant Lung Neoplasm;   Metastatic Malignant Neoplasm in the Lung;   Non-Small Cell Lung Carcinoma;   Stage IV Lung Cancer
Interventions: Radiation: Computed Tomography Perfusion Imaging;   Other: Laboratory Biomarker Analysis
28 Recruiting Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
Conditions: Non-small Cell Lung Cancer;   Advanced Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Hydroxychloroquine;   Drug: Bevacizumab
29 Completed Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
Conditions: Non-Small Cell Lung Carcinoma;   Small Cell Lung Cancer
Intervention: Procedure: Biopsy samples
30 Active, not recruiting A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
Conditions: Non-Small Cell Lung Cancer;   Squamous Non-Small Cell Lung Cancer;   NSCLC;   Small Cell Lung Cancer;   SCLC;   Lung Cancer;   Advanced Lung Cancer;   Metastatic Lung Cancer;   Stage IV Lung Cancer
Intervention: Drug: Lucitanib
31 Completed
Has Results
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
Conditions: Lung Cancer;   Small Cell Lung Cancer;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Ipilimumab;   Drug: Placebo;   Drug: Paclitaxel;   Drug: Carboplatin
32 Recruiting Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Radiation: hypofractionated radiation therapy;   Drug: cisplatin;   Drug: etoposide;   Radiation: 3-dimensional conformal radiation therapy;   Other: laboratory biomarker analysis
33 Completed Breath Test for Early Detection of Lung Cancer
Condition: Lung Neoplasms
Intervention: Device: Breath Collection Apparatus
34 Unknown  Biomarkers for Diagnosis of Lung Cancer
Conditions: Lung Cancer;   Lung Neoplasm
Intervention:
35 Recruiting Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic;   Small Cell Lung Carcinoma
Intervention: Other: therapeutic interventions
36 Terminated
Has Results
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
Conditions: Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Recurrent Non-Small Cell Lung Carcinoma;   Stage IV Non-Small Cell Lung Cancer;   Bronchioloalveolar Lung Carcinoma
Interventions: Biological: Bevacizumab;   Drug: Carboplatin;   Biological: Cixutumumab;   Drug: Paclitaxel
37 Terminated Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Stage IIIB;   Non-small Cell Lung Cancer Stage IV;   Non-small Cell Lung Cancer Metastatic
Interventions: Drug: Docetaxel;   Drug: Combination of ganetespib and docetaxel
38 Recruiting Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
Condition: Lung Neoplasms
Intervention:
39 Completed Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung;   Lung Neoplasms
Interventions: Drug: paclitaxel;   Drug: cisplatin;   Procedure: chest radiotherapy
40 Completed Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer
Conditions: Lung Neoplasm;   Small Cell Carcinoma
Intervention: Radiation: Hypofractionated Chest Radiotherapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years